Location History:
- Blausasc, FR (2005)
- Grasse, FR (2014)
Company Filing History:
2 out of 5,099 
1 out of 23 
1 out of 12 
Years Active: 2005-2014
Title: Gérard Lambeau: Innovator in Diagnostic Methods
Introduction
Gérard Lambeau is a notable inventor based in Grasse, France. He has made significant contributions to the field of diagnostics, particularly in the detection of plasmodium infections. With a total of 2 patents, his work has implications for both medical research and clinical applications.
Latest Patents
Lambeau's latest patents include innovative methods for diagnosing plasmodium infections. The first patent outlines in vitro methods that involve measuring the serum concentration of specific secreted phospholipases A, namely GIIF, GV, and GX, in blood samples. This method aims to enhance the accuracy of diagnosing infections in subjects. The second patent focuses on the DNA and peptide sequences encoding a mammalian secreted group III phospholipase A2, particularly the human variant. This invention is crucial for screening various chemical compounds in research settings.
Career Highlights
Throughout his career, Gérard Lambeau has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Nice-Sophia Antipolis. His research has contributed to advancements in the understanding of phospholipases and their applications in medical diagnostics.
Collaborations
Lambeau has collaborated with notable colleagues, including Michel Lazdunski and Emmanuel Valentin. Their joint efforts have furthered research in the field of biochemistry and diagnostics.
Conclusion
Gérard Lambeau's contributions to the field of diagnostics through his innovative patents highlight his role as a significant inventor. His work continues to influence medical research and diagnostic methodologies.